OBJECTIVE
To evaluate the efficacy and tolerance of topical 4HBAP (para-topolin [6-(4-hydroxybenzylamino) purine], a new aromatic cytokinin, in subjects with mild to moderate facial photodamage.
METHODS
In this single-center, 12-week study subjects (n=39) applied topical 0.10% 4HBAP (the test